MERLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 963
AS - Asia 709
EU - Europa 563
SA - Sud America 67
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.314
Nazione #
US - Stati Uniti d'America 936
CN - Cina 378
IE - Irlanda 166
SG - Singapore 141
RU - Federazione Russa 92
HK - Hong Kong 85
FI - Finlandia 72
BR - Brasile 59
DE - Germania 56
IN - India 36
UA - Ucraina 36
IT - Italia 35
VN - Vietnam 29
GB - Regno Unito 26
SE - Svezia 24
CA - Canada 20
FR - Francia 19
PL - Polonia 11
JP - Giappone 9
TR - Turchia 7
MX - Messico 5
NL - Olanda 5
AR - Argentina 4
BE - Belgio 4
ZA - Sudafrica 4
ES - Italia 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
GR - Grecia 2
ID - Indonesia 2
NP - Nepal 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
CG - Congo 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 2.314
Città #
Dublin 166
Chandler 145
Beijing 100
San Jose 86
Ashburn 85
Hong Kong 83
Singapore 82
Nanjing 72
Jacksonville 65
Dallas 52
Boardman 41
Los Angeles 37
Nanchang 31
Helsinki 30
Ann Arbor 26
New York 26
Changsha 24
Princeton 24
Wilmington 24
Lawrence 23
Munich 20
Pune 20
Shanghai 20
Medford 16
Shenyang 16
Hebei 15
Jiaxing 14
Tianjin 14
Moscow 11
Redondo Beach 11
Hanoi 9
Milan 9
San Francisco 9
Tokyo 9
Warsaw 9
Toronto 8
Woodbridge 8
Columbus 7
Pavia 7
Stockholm 7
São Paulo 7
The Dalles 7
Buffalo 6
Chennai 6
Montreal 6
Turku 6
Denver 5
Ho Chi Minh City 5
Manchester 5
Orem 5
Phoenix 5
Santa Clara 5
Brussels 4
Chicago 4
Falkenstein 4
Frankfurt am Main 4
Guangzhou 4
Hangzhou 4
Norwalk 4
Ankara 3
Belo Horizonte 3
Brooklyn 3
Calgary 3
Johannesburg 3
Lauterbourg 3
London 3
Zhengzhou 3
Athens 2
Baku 2
Bengaluru 2
Charlotte 2
Fairfield 2
Jinan 2
Lanzhou 2
Lavras 2
Milwaukee 2
Mumbai 2
New Delhi 2
Ningbo 2
Nuremberg 2
Olomouc 2
Paris 2
Poplar 2
Ribeirão Preto 2
Rio Grande 2
Seattle 2
São José dos Campos 2
Tashkent 2
Wuhan 2
Addis Ababa 1
Aktobe 1
Amsterdam 1
Andradina 1
Annapolis 1
Aparecida de Goiânia 1
Aracaju 1
Asunción 1
Atlanta 1
Auburn Hills 1
Baghdad 1
Totale 1.636
Nome #
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 146
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 128
High resolution genome-wide array-comparative genomic hybridization in splenic marginal zone B-cell lymphoma 113
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 110
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 109
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 107
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 106
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma 101
Everolimus in diffuse large B-cell lymphomas 99
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 96
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 95
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. 95
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. 93
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. 89
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 89
Antiviral therapies for managing viral hepatitis in lymphoma patients 88
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 87
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy 86
The NOTCH pathway is recurrently mutated in diffuse large B cell lymphoma associated with hepatitis C virus infection. 81
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 77
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. 73
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. 71
Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi 60
Rituximab maintenance in follicular lymphoma patients 56
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms 55
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi 44
null 21
Totale 2.375
Categoria #
all - tutte 10.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 1 20 12 14 9 3
2021/202299 3 2 4 0 5 0 0 9 3 0 16 57
2022/2023414 35 43 5 26 40 36 0 17 192 1 10 9
2023/2024184 17 36 8 10 11 56 3 13 1 12 6 11
2024/2025445 10 28 14 4 7 43 7 25 132 19 65 91
2025/2026675 97 54 93 109 142 62 118 0 0 0 0 0
Totale 2.375